Structure and Biophysics, Discovery Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, UK.
Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, Garscube Campus, University of Glasgow, Glasgow G61 1QQ, UK.
Int J Mol Sci. 2021 May 12;22(10):5112. doi: 10.3390/ijms22105112.
Poly (ADP-ribose) polymerases (PARP) 1-3 are well-known multi-domain enzymes, catalysing the covalent modification of proteins, DNA, and themselves. They attach mono- or poly-ADP-ribose to targets using NAD as a substrate. Poly-ADP-ribosylation (PARylation) is central to the important functions of PARP enzymes in the DNA damage response and nucleosome remodelling. Activation of PARP happens through DNA binding via zinc fingers and/or the WGR domain. Modulation of their activity using PARP inhibitors occupying the NAD binding site has proven successful in cancer therapies. For decades, studies set out to elucidate their full-length molecular structure and activation mechanism. In the last five years, significant advances have progressed the structural and functional understanding of PARP1-3, such as understanding allosteric activation via inter-domain contacts, how PARP senses damaged DNA in the crowded nucleus, and the complementary role of histone PARylation factor 1 in modulating the active site of PARP. Here, we review these advances together with the versatility of PARP domains involved in DNA binding, the targets and shape of PARylation and the role of PARPs in nucleosome remodelling.
多聚(ADP-核糖)聚合酶(PARP)1-3 是众所周知的多结构域酶,可催化蛋白质、DNA 和自身的共价修饰。它们使用 NAD 作为底物,将单聚或多聚 ADP-核糖连接到靶标上。聚 ADP-核糖基化(PARylation)是 PARP 酶在 DNA 损伤反应和核小体重塑中重要功能的核心。PARP 的激活是通过锌指和/或 WGR 结构域与 DNA 的结合来实现的。使用占据 NAD 结合位点的 PARP 抑制剂来调节它们的活性已被证明在癌症治疗中是成功的。几十年来,研究人员致力于阐明它们全长的分子结构和激活机制。在过去的五年中,PARP1-3 的结构和功能理解取得了重大进展,例如通过域间接触理解别构激活、PARP 如何在拥挤的核中感知受损的 DNA,以及组蛋白 PAR 化因子 1 对调节 PARP 活性位点的互补作用。在这里,我们一起回顾这些进展,以及 PARP 结构域在 DNA 结合、PARylation 的靶标和形状以及 PARP 在核小体重塑中的作用的多功能性。